» Articles » PMID: 29096713

Method and Key Points for Isolation of Human Amniotic Epithelial Cells with High Yield, Viability and Purity

Overview
Journal BMC Res Notes
Publisher Biomed Central
Date 2017 Nov 4
PMID 29096713
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Human amniotic epithelial cells (hAECs) which are isolated from the amniotic membrane have stem cell-like properties and immunomodulatory effects. Several protocols have been proposed for isolation of hAECs, nevertheless, there is no report concerning isolation of highly viable hAECs, with desirable yield, and without significant purity reduction. In the current study, a detailed protocol with some modification of previous ones is presented in which the amendments led to isolation of hAECs with high purity, yield and viability. Moreover, isolated hAECs were subjected to immuno-phenotyping and their physiological status was assessed using a proliferation assay.

Results: The average yield of obtained hAECs using the new modified method was 190 × 10 cells with a mean viability of 87%, with less than 1% contamination with mesenchymal stem cells (MSCs). The isolated cells were > 95% positive for the epithelial cell markers. The lowest initial plating efficiency of the cells was 80%. Freshly isolated hAECs had the ability to proliferate for 5-6 passages in a standard culture medium.

Citing Articles

Reinvesting the cellular properties of human amniotic epithelial cells and their therapeutic innovations.

Yang J, Lu Y, Zhao J, Luo Y, Hao W, Zhang W Front Immunol. 2024; 15:1466529.

PMID: 39474414 PMC: 11518714. DOI: 10.3389/fimmu.2024.1466529.


Therapeutic potential of extracellular vesicles derived from human amniotic epithelial cells for perinatal cerebral and pulmonary injury.

Kumar N, Bidkhori H, Yawno T, Lim R, Inocencio I Stem Cells Transl Med. 2024; 13(8):711-723.

PMID: 38895873 PMC: 11328935. DOI: 10.1093/stcltm/szae037.


Human Amniotic Epithelial Stem Cells Alleviate Autoimmune Premature Ovarian Insufficiency in Mice by Targeting Granulosa Cells via AKT/ERK Pathways.

Ye X, Lin Y, Ying Y, Shen X, Ni F, Wang F Stem Cell Rev Rep. 2024; 20(6):1618-1635.

PMID: 38831179 PMC: 11319531. DOI: 10.1007/s12015-024-10745-z.


Comparison of the Efficacy of Two Routes of Administration of Human Amniotic Epithelial Cells in Cell Therapy of Acute Hepatic Insufficiency.

Wieczorek P, Czekaj P, Krol M, Bogunia E, Hermyt M, Kolanko E Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675436 PMC: 11054846. DOI: 10.3390/ph17040476.


The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers.

Jafari S, Motedayyen H, Javadi P, Jamali K, Hasan-Abad A, Atapour A Front Oncol. 2024; 14:1355064.

PMID: 38559560 PMC: 10978783. DOI: 10.3389/fonc.2024.1355064.


References
1.
Miki T, Lehmann T, Cai H, Stolz D, Strom S . Stem cell characteristics of amniotic epithelial cells. Stem Cells. 2005; 23(10):1549-59. DOI: 10.1634/stemcells.2004-0357. View

2.
Liu Y, Vaghjiani V, Tee J, To K, Cui P, Oh D . Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis. PLoS One. 2012; 7(4):e35758. PMC: 3338525. DOI: 10.1371/journal.pone.0035758. View

3.
Miki T, Marongiu F, Dorko K, Ellis E, Strom S . Isolation of amniotic epithelial stem cells. Curr Protoc Stem Cell Biol. 2010; Chapter 1:Unit 1E.3. DOI: 10.1002/9780470151808.sc01e03s12. View

4.
Toda A, Okabe M, Yoshida T, Nikaido T . The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci. 2007; 105(3):215-28. DOI: 10.1254/jphs.cr0070034. View

5.
Kakishita K, Elwan M, Nakao N, Itakura T, Sakuragawa N . Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: a potential source of donor for transplantation therapy. Exp Neurol. 2000; 165(1):27-34. DOI: 10.1006/exnr.2000.7449. View